breast-cancer-vascular-conference-2019-scientifictracks

3 / 8

Page 21
Notes:
Volume 2 Journal of Molecular Cancer Breast Cancer & Vascular Conference 2019
February 25-26, 2019
February 25-26, 2019 London, UK
Joint event on
World Congress on Breast Cancer
Vascular Biology & Surgeons Meeting
5th International Conference on
&
Multidisciplinary patient navigation program improves compliance with adjuvant therapy
Maria Castaldi
Albert Einstein College of Medicine, USA
Cancer health disparities affecting low-income and minority patients have been well documented as leading to poor outcomes. This
report examines the impact of patient navigation on adherence to prescribed adjuvant breast cancer treatment.AMultidisciplinary
Patient Navigation Program was initiated at a public safety net hospital to improve compliance with three National Quality Forum
(NQF) measures: 1) Administration of combination chemotherapy for women with Stage (defined by the American Joint Committee
on Cancer, AJCC) T1c, II, or III hormone receptor negative (HRN) breast cancer within 120 days, and 2) Administration of endocrine
therapy (HT) for women withAJCC Stage T1c, II, or III hormone receptor positive breast cancer (HRP) within 365 days. 3) Radiation
therapy (xRT) for women receiving breast conserving surgery (BCS) within one year. Implementation of a multidisciplinary patient
navigation program reduced time to treatment and improved compliance with adjuvant therapy for breast cancer in an underserved
minority community.
Biography
Maria Castaldi currently working in the Albert Einstein College of Medicine, Bronx, graduated from Albert Einstein College of Medicine, Bronx, new York. Her
research interest is Breast cancer.
Falah AM Salih, J Molecular Cancer
Volume 2